SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
(Translation of Registrant’s Name into English)
P.O. Box 544
Migdal Haemek 23150
ISRAEL
(Address of Principal Corporate Offices)
|
CAMTEK LTD.
(Registrant) By: /s/ Moshe Eisenberg —————————————— Moshe Eisenberg, Chief Financial Officer |
![]() |
Camtek Ltd.
P.O.Box 544, Ramat Gabriel Industrial Park
Migdal Ha’Emek 23150, ISRAEL
Tel: +972 (4) 604-8100 Fax: +972 (4) 644-0523
E-Mail: [email protected] Web site: http://www.camtek.com
|
|
CAMTEK LTD.
Moshe Eisenberg, CFO
Tel: +972 4 604 8308
Mobile: +972 54 900 7100
|
INTERNATIONAL INVESTOR RELATIONS
EK Global Investor Relations
Ehud Helft
Tel: (US) 1 212 378 8040 |
| • |
Record revenues of $126.0 million, a 12% YoY increase;
|
| • |
GAAP gross margin of 50.0% and non-GAAP gross margin of 51.5%;
|
| • |
GAAP operating income of $31.8 million (up 8% YoY) and non-GAAP operating income of $37.6 million (up 10% YoY), representing operating margins of 25.3% and 29.9%, respectively;
|
| • |
$500 million raised via new offering of convertible notes;
|
| • |
The GAAP results include a one-time capital loss of $89 million, net, related to the repurchase of 83% of the 2021 convertible notes which led to a GAAP net loss of $53.2 million and EPS of $(1.16); non-GAAP net income of $40.9 million (up
10% YoY); non-GAAP diluted EPS of $0.82; and
|
| • |
Generated cash of over $34 million from operating activities.
|
|
September 30,
|
December 31,
|
|||||||
|
2025
|
2024
|
|||||||
|
U.S. Dollars
|
||||||||
|
Assets
|
||||||||
|
Current assets
|
||||||||
|
Cash and cash equivalents
|
199,671
|
126,224
|
||||||
|
Short-term deposits
|
382,450
|
231,000
|
||||||
|
Marketable securities
|
57,373
|
30,813
|
||||||
|
Trade accounts receivable, net
|
112,502
|
99,471
|
||||||
|
Inventories
|
126,492
|
111,204
|
||||||
|
Other current assets
|
21,337
|
21,347
|
||||||
|
Total current assets
|
899,825
|
620,059
|
||||||
|
Long-term deposits
|
20,000
|
26,000
|
||||||
|
Marketable securities
|
134,460
|
87,115
|
||||||
|
Long-term inventory
|
16,131
|
11,879
|
||||||
|
Deferred tax asset, net
|
10,858
|
3,090
|
||||||
|
Other assets, net
|
2,493
|
2,001
|
||||||
|
Property, plant and equipment, net
|
62,214
|
54,196
|
||||||
|
Intangible assets, net
|
10,736
|
13,357
|
||||||
|
Goodwill
|
74,345
|
74,345
|
||||||
|
Total non- current assets
|
331,237
|
271,983
|
||||||
|
Total assets
|
1,231,062
|
892,042
|
||||||
|
Liabilities and shareholders’ equity
|
||||||||
|
Current liabilities
|
||||||||
|
Trade accounts payable
|
33,232
|
46,630
|
||||||
|
Other current liabilities
|
85,463
|
77,280
|
||||||
|
Total current liabilities
|
118,695
|
123,910
|
||||||
|
Long-term liabilities
|
||||||||
|
Deferred tax liabilities, net
|
-
|
5,606
|
||||||
|
Other long-term liabilities
|
15,220
|
15,366
|
||||||
|
Convertible notes
|
519,111
|
197,925
|
||||||
|
Total long-term liabilities
|
534,331
|
218,897
|
||||||
|
Total liabilities
|
653,026
|
342,807
|
||||||
|
Commitments and contingencies
|
||||||||
|
Shareholders’ equity
|
||||||||
|
Ordinary shares NIS 0.01 par value, 100,000,000 shares authorized at September 30, 2025, and at December 31, 2024;
|
||||||||
|
47,858,633 issued shares at September 30, 2025, and 47,541,682 at December 31, 2024;
|
||||||||
|
45,766,257 shares outstanding at September 30, 2025, and 45,449,306 at December 31, 2024
|
178
|
177
|
||||||
|
Additional paid-in capital
|
227,589
|
214,931
|
||||||
|
Accumulated other comprehensive income (loss)
|
1,520
|
203
|
||||||
|
Retained earnings
|
350,647
|
335,822
|
||||||
|
579,934
|
551,133
|
|||||||
|
Treasury stock, at cost (2,092,376 shares as of September 30, 2025, and December 31, 2024)
|
(1,898
|
)
|
(1,898
|
)
|
||||
|
Total shareholders' equity
|
578,036
|
549,235
|
||||||
|
Total liabilities and shareholders' equity
|
1,231,062
|
892,042
|
||||||
|
Nine months ended
September 30,
|
Three months
ended September 30,
|
Year ended
December 31,
|
||||||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
2024
|
||||||||||||||||
|
U.S. dollars
|
U.S. dollars
|
U.S. dollars
|
||||||||||||||||||
|
Revenues
|
367,948
|
311,941
|
125,993
|
112,340
|
429,234
|
|||||||||||||||
|
Cost of revenues
|
181,731
|
160,122
|
62,951
|
56,484
|
219,283
|
|||||||||||||||
|
Gross profit
|
186,217
|
151,819
|
63,042
|
55,856
|
209,951
|
|||||||||||||||
|
Operating expenses:
|
||||||||||||||||||||
|
Research and development
|
35,289
|
27,916
|
13,453
|
9,770
|
38,287
|
|||||||||||||||
|
Selling, general and administrative
|
54,409
|
47,134
|
17,744
|
16,440
|
63,595
|
|||||||||||||||
|
Total operating expenses
|
89,698
|
75,050
|
31,197
|
26,210
|
101,882
|
|||||||||||||||
|
Operating income
|
96,519
|
76,769
|
31,845
|
29,646
|
108,069
|
|||||||||||||||
|
Financial income, net
|
16,901
|
16,994
|
6,526
|
6,370
|
23,169
|
|||||||||||||||
|
Other expenses
|
(100,932
|
)
|
-
|
(100,932
|
)
|
-
|
-
|
|||||||||||||
|
Income (loss) before income taxes
|
12,488
|
93,763
|
(62,561
|
)
|
36,016
|
131,238
|
||||||||||||||
|
Income tax benefit (expense)
|
2,337
|
(8,257
|
)
|
9,380
|
(3,273
|
)
|
(12,723
|
)
|
||||||||||||
|
Net income (loss)
|
14,825
|
85,506
|
(53,181
|
)
|
32,743
|
118,515
|
||||||||||||||
|
Earnings per share information:
|
Nine months ended
September 30,
|
Three months
ended September 30,
|
Year ended
December 31,
|
|||||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
2024
|
||||||||||||||||
|
U.S. dollars
|
U.S. dollars
|
U.S. dollars
|
||||||||||||||||||
|
Basic net earnings (loss) per share (in US dollars)
|
0.32
|
1.89
|
(1.16
|
)
|
0.72
|
2.62
|
||||||||||||||
|
Diluted net earnings (loss) per share (in US dollars)
|
0.32
|
1.73
|
(1.16
|
)
|
0.66
|
2.42
|
||||||||||||||
|
Weighted average number of
|
||||||||||||||||||||
|
ordinary shares outstanding:
|
||||||||||||||||||||
|
Basic
|
45,655
|
45,176
|
45,755
|
45,365
|
45,279
|
|||||||||||||||
|
Diluted
|
49,502
|
49,333
|
45,755
|
49,437
|
49,369
|
|||||||||||||||
|
Nine Months ended
September 30,
|
Three Months ended
September 30,
|
Year ended
December 31,
|
||||||||||||||||||
| 2025 |
2024
|
2025 |
2024
|
2024
|
||||||||||||||||
|
U.S. dollars
|
U.S. dollars
|
U.S. dollars
|
||||||||||||||||||
|
Reported net income attributable to Camtek Ltd. on GAAP basis
|
14,825
|
85,506
|
(53,181
|
)
|
32,743
|
118,515
|
||||||||||||||
|
Acquisition of FRT-related expenses (1)
|
2,268
|
4,684
|
968
|
650
|
5,334
|
|||||||||||||||
|
Loss from extinguishment of Capital Notes (2)
|
88,682
|
-
|
88,682
|
-
|
-
|
|||||||||||||||
|
Share-based compensation
|
12,586
|
10,723
|
4,383
|
3,614
|
14,775
|
|||||||||||||||
|
Non-GAAP net income
|
118,361
|
100,913
|
40,852
|
37,007
|
138,624
|
|||||||||||||||
|
Non–GAAP net income per diluted share
|
2.42
|
2.05
|
0.82
|
0.75
|
2.83
|
|||||||||||||||
|
Gross margin on GAAP basis
|
50.6
|
%
|
48.7
|
%
|
50.0
|
%
|
49.7
|
%
|
49.6
|
%
|
||||||||||
|
Reported gross profit on GAAP basis
|
186,217
|
151,819
|
63,042
|
55,856
|
209,951
|
|||||||||||||||
|
Acquisition of FRT-related expenses (1)
|
2,285
|
5,192
|
1,065
|
610
|
5,802
|
|||||||||||||||
|
Share-based compensation
|
2,094
|
1,602
|
750
|
596
|
2,197
|
|||||||||||||||
|
Non- GAAP gross profit
|
190,596
|
158,613
|
64,857
|
57,062
|
217,950
|
|||||||||||||||
|
Non-GAAP gross margin
|
51.8
|
%
|
50.8
|
%
|
51.5
|
%
|
50.8
|
%
|
50.8
|
%
|
||||||||||
|
Reported operating income attributable to Camtek Ltd. on GAAP basis
|
96,519
|
76,769
|
31,845
|
29,646
|
108,069
|
|||||||||||||||
|
Acquisition of FRT related expenses (1)
|
3,239
|
6,527
|
1,383
|
928
|
7,455
|
|||||||||||||||
|
Share-based compensation
|
12,586
|
10,723
|
4,383
|
3,614
|
14,775
|
|||||||||||||||
|
Non-GAAP operating income
|
112,344
|
94,019
|
37,611
|
34,188
|
130,299
|
|||||||||||||||
